| Literature DB >> 22111916 |
Maria de la Paz Celorio-Mancera1, Seung-Joon Ahn, Heiko Vogel, David G Heckel.
Abstract
BACKGROUND: Hormesis is a biphasic biological response characterized by the stimulatory effect at relatively low amounts of chemical compounds which are otherwise detrimental at higher concentrations. A hormetic response in larval growth rates has been observed in cotton-feeding insects in response to increasing concentrations of gossypol, a toxic metabolite found in the pigment glands of some plants in the family Malvaceae. We investigated the developmental effect of gossypol in the cotton bollworm, Helicoverpa armigera, an important heliothine pest species, by exposing larvae to different doses of this metabolite in their diet. In addition, we sought to determine the underlying transcriptional responses to different gossypol doses.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22111916 PMCID: PMC3235194 DOI: 10.1186/1471-2164-12-575
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Hormetic effect of gossypol on larval development. Net larval weight gain (mg) (A) and pupal weight recorded one day after pupation (mg) (B) are plotted against the logarithm of gossypol concentration (mg/L). Means that are not indicated with the same letter are significantly different from each other as determined by post-hoc Duncan tests (P < 0.05) (feeding treatments T5 = 0.016%; T7 = 0.16% gossypol in insect diet).
GO categories enriched in microarray comparisons through gossypol-tissue treatments
| GO accession | GO term | Corrected p-value | |
|---|---|---|---|
| GO:0055114 | oxidation reduction | 7.19E-19 | |
| GO:0016491 | oxidoreductase activity | 1.94E-18 | |
| GO:0044429 | mitochondrial part | 4.01E-15 | |
| GO:0005739 | mitochondrion | 2.28E-14 | |
| GO:0005740 | mitochondrial envelope | 1.50E-10 | |
| GO:0031966 | mitochondrial membrane | 2.77E-09 | |
| GO:0003824 | catalytic activity | 6.22E-08 | |
| GO:0031967 | organelle envelope | 6.77E-08 | |
| GO:0005743 | mitochondrial inner membrane | 7.14E-08 | |
| GO:0019866 | organelle inner membrane | 7.76E-08 | |
| GO:0031975 | envelope | 5.36E-07 | |
| GO:0031090 | organelle membrane | 7.13E-07 | |
| GO:0044444 | cytoplasmic part | 6.98E-05 | |
| GO:0015992 | proton transport | 7.52E-05 | |
| GO:0006818 | hydrogen transport | 8.16E-05 | |
| GO:0006091 | generation of precursor metabolites and energy | 8.16E-05 | |
| GO:0042180 | cellular ketone metabolic process | 1.27E-04 | |
| GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 3.16E-04 | |
| GO:0019752 | carboxylic acid metabolic process | 3.50E-04 | |
| GO:0043436 | oxoacid metabolic process | 3.50E-04 | |
| GO:0006082 | organic acid metabolic process | 3.50E-04 | |
| GO:0005759 | mitochondrial matrix | 4.27E-04 | |
| GO:0031980 | mitochondrial lumen | 4.27E-04 | |
| GO:0008610 | lipid biosynthetic process | 4.81E-04 | |
| GO:0015672 | monovalent inorganic cation transport | 4.81E-04 | |
| GO:0005506 | iron ion binding | 7.97E-04 | |
| GO:0007156 | homophilic cell adhesion | 1.90E-05 | |
| GO:0016337 | cell-cell adhesion | 2.83E-04 | |
| GO:0070003 | threonine-type peptidase activity | 4.38E-12 | |
| GO:0051603 | proteolysis involved in cellular protein catabolic process | 3.93E-14 | |
| GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 3.99E-05 | |
| GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.12E-04 | |
| GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.12E-04 | |
| GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.12E-04 | |
| GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.12E-04 | |
| GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.99E-05 | |
| GO:0051352 | negative regulation of ligase activity | 3.99E-05 | |
| GO:0051351 | positive regulation of ligase activity | 3.00E-04 | |
| GO:0051340 | regulation of ligase activity | 3.00E-04 | |
| GO:0044265 | cellular macromolecule catabolic process | 2.67E-11 | |
| GO:0044257 | cellular protein catabolic process | 3.93E-14 | |
| GO:0043632 | modification-dependent macromolecule catabolic process | 5.52E-10 | |
| GO:0043234 | protein complex | 2.38E-08 | |
| GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.12E-04 | |
| GO:0031398 | positive regulation of protein ubiquitination | 1.86E-04 | |
| GO:0031397 | negative regulation of protein ubiquitination | 3.99E-05 | |
| GO:0031396 | regulation of protein ubiquitination | 4.83E-04 | |
| GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.99E-05 | |
| GO:0030163 | protein catabolic process | 8.38E-17 | |
| GO:0022624 | proteasome accessory complex | 4.28E-08 | |
| GO:0019941 | modification-dependent protein catabolic process | 5.52E-10 | |
| GO:0019773 | proteasome core complex, alpha-subunit complex | 8.26E-04 | |
| GO:0010498 | proteasomal protein catabolic process | 1.12E-04 | |
| GO:0009057 | macromolecule catabolic process | 3.09E-09 | |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 4.88E-10 | |
| GO:0006508 | proteolysis | 1.86E-04 | |
| GO:0005839 | proteasome core complex | 4.38E-12 | |
| GO:0005838 | proteasome regulatory particle | 6.90E-09 | |
| GO:0004298 | threonine-type endopeptidase activity | 4.38E-12 | |
| GO:0000502 | proteasome complex | 2.60E-29 | |
| GO:0016491 | oxidoreductase activity | 9.14E-24 | |
| GO:0055114 | oxidation reduction | 7.45E-20 | |
| GO:0042302 | structural constituent of cuticle | 6.83E-13 | |
| GO:0050662 | coenzyme binding | 1.18E-12 | |
| GO:0048037 | cofactor binding | 1.18E-12 | |
| GO:0050660 | FAD or FADH2 binding | 1.16E-08 | |
| GO:0003824 | catalytic activity | 3.37E-08 | |
| GO:0006066 | alcohol metabolic process | 2.52E-07 | |
| GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 2.52E-07 |
Statistically filtered transcriptional responses per H. armigera tissue (Welch's t-test, B&H FDR corrected P < 0.001) relative to gossypol-free diet expression data was subjected to GO enrichment analysis (P < 0.01) using Agilent GeneSpring GX11.5.1 software (Gossypol concentration: T5 = 0.016%, T7 = 0.16%).
Figure 2Expression of detoxification gene families across gossypol dose-tissue experimental conditions. Transcriptional responses of cytochrome P450 s, esterases, UDP-glycosyltransferases and glutathione transferases in gut and the rest of the body are displayed for two gossypol concentrations (CT: 0%; T5: 0.016%; T7: 0.16%). Responses are expressed relative to the median intensity of all data (blue = down-regulation; black = no change; red = up-regulation). Genes were found to be differentially expressed in H. armigera rest of body (RB) larval tissue to a 0.16% (T7) gossypol in the diet relative to the control samples (Welch's t-test, B&H FDR P < 0.001).
Figure 3KEGG pathway analysis on differentially regulated genes across gossypol dose-tissue experimental conditions. Charts depict the proportion of genes, using fruit fly gene homology to H. armigera ESTs represented in the microarray, belonging to pathways occurring more or less frequently than expected in the test group relative to control (gossypol-free diet). Arrows indicate directionality of regulation for the corresponding genes in the pathway associated with significant z-scores (minimum number in gene set = 10) (Tissue: G = gut, RB = rest of body; Gossypol concentration: T5 = 0.016%, T7 = 0.16%).
Figure 4Transcriptional response of energy acquisition and oxidative stress-related genes across experimental conditions. Gene expression was found to be differentially regulated by the Rank Products method. The average of the normalized log-ratios across biological replicates for two probes representing each gene is plotted. The ratio is represented by either T5 (0.016%) or T7 (0.16%) over the control (0% gossypol) across tissues.
Figure 5Transcriptional response of a selection of putative detoxification genes across experimental conditions. Gene expression was found to be differentially regulated by the Rank Products method. The average of the normalized log-ratios across biological replicates for two probes representing each gene is plotted. The ratio is represented by either T5 (0.016%) or T7 (0.16%) over the control (0% gossypol) across tissues.